title: CTCF binding to the first intron of the major immediate early (MIE) gene of human cytomegalovirus (HCMV) negatively regulates MIE gene expression and HCMV replication.
abstract: Human cytomegalovirus (HCMV) gene expression during infection is highly regulated, with sequential expression of immediate-early (IE), early (E), and late (L) gene transcripts. To explore the potential role of chromatin regulatory factors that may regulate HCMV gene expression and DNA replication, we investigated the interaction of HCMV with the cellular chromatin-organizing factor CTCF. Here, we show that HCMV-infected cells produce higher levels of CTCF mRNA and protein at early stages of infection. We also show that CTCF depletion by short hairpin RNA results in an increase in major IE (MIE) and E gene expression and an about 50-fold increase in HCMV particle production. We identified a DNA sequence (TTAACGGTGGAGGGCAGTGT) in the first intron (intron A) of the MIE gene that interacts directly with CTCF. Deletion of this CTCF-binding site led to an increase in MIE gene expression in both transient-transfection and infection assays. Deletion of the CTCF-binding site in the HCMV bacterial artificial chromosome plasmid genome resulted in an about 10-fold increase in the rate of viral replication relative to either wild-type or revertant HCMV. The CTCF-binding site deletion had no detectable effect on MIE gene-splicing regulation, nor did CTCF knockdown or overexpression of CTCF alter the ratio of IE1 to IE2. Therefore, CTCF binds to DNA within the MIE gene at the position of the first intron to affect RNA polymerase II function during the early stages of viral transcription. Finally, the CTCF-binding sequence in CMV is evolutionarily conserved, as a similar sequence in murine CMV (MCMV) intron A was found to interact with CTCF and similarly function in the repression of MCMV MIE gene expression mediated by CTCF.
  
  
  OBJECTIVE
  Our findings that CTCF binds to intron A of the cytomegalovirus (CMV) major immediate-early (MIE) gene and functions to repress MIE gene expression and viral replication are highly significant. For the first time, a chromatin-organizing factor, CTCF, has been found to facilitate human CMV gene expression, which affects viral replication. We also identified a CTCF-binding motif in the first intron (also called intron A) that directly binds to CTCF and is required for CTCF to repress MIE gene expression. Finally, we show that the CTCF-binding motif is conserved in CMV because a similar DNA sequence was found in murine CMV (MCMV) that is required for CTCF to bind to MCMV MIE gene to repress MCMV MIE gene expression.
authors.affiliation: Department of Microbiology/RCMI Program, Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico, USA.
authors.forename: Francisco Puerta
authors.initials: FP
authors.lastname: Martínez
authors.affiliation: Department of Microbiology/RCMI Program, Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico, USA.
authors.forename: Ruth
authors.initials: R
authors.lastname: Cruz
authors.affiliation: The Wistar Institute, Philadelphia, Pennsylvania, USA.
authors.forename: Fang
authors.initials: F
authors.lastname: Lu
authors.affiliation: Cell and Molecular Biology Department, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Plasschaert
authors.affiliation: The Wistar Institute, Philadelphia, Pennsylvania, USA.
authors.forename: Zhong
authors.initials: Z
authors.lastname: Deng
authors.affiliation: Department of Microbiology/RCMI Program, Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico, USA.
authors.forename: Yisel A
authors.initials: YA
authors.lastname: Rivera-Molina
authors.affiliation: Cell and Molecular Biology Department, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
authors.forename: Marisa S
authors.initials: MS
authors.lastname: Bartolomei
authors.affiliation: The Wistar Institute, Philadelphia, Pennsylvania, USA.
authors.forename: Paul M
authors.initials: PM
authors.lastname: Lieberman
authors.affiliation: Department of Microbiology/RCMI Program, Ponce School of Medicine and Health Sciences, Ponce, Puerto Rico, USA qtang@psm.edu.
authors.forename: Qiyi
authors.initials: Q
authors.lastname: Tang
mesh_terms: D001483:Base Sequence; D000076246:CCCTC-Binding Factor; D003587:Cytomegalovirus / Q000502:physiology; D003586:Cytomegalovirus Infections / Q000235:genetics / Q000378:metabolism / Q000821:virology*; D024202:Electrophoretic Mobility Shift Assay; D015967:Gene Expression Regulation, Viral; D057809:HEK293 Cells; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics* / Q000378:metabolism; D015151:Immunoblotting; D007438:Introns / Q000502:physiology*; D008969:Molecular Sequence Data; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism*; D015534:Trans-Activators / Q000235:genetics* / Q000378:metabolism; D014779:Virus Replication / Q000502:physiology*
chemical_list: D000076246:CCCTC-Binding Factor; C000619697:CTCF protein, human; C088645:IE1 protein, cytomegalovirus; C069186:IE2 protein, Cytomegalovirus; D017874:Immediate-Early Proteins; D012097:Repressor Proteins; D015534:Trans-Activators
references.citation: J Virol. 2005 Jan;79(1):257-63
references.pmid: 15596821
references.citation: J Virol. 2011 Nov;85(22):11928-37
references.pmid: 21880768
references.citation: Curr Protoc Chem Biol. 2009 Dec 1;1(1):1-15
references.pmid: 23839960
references.citation: Cell. 1988 Dec 2;55(5):857-68
references.pmid: 2847874
references.citation: J Virol. 2007 Sep;81(17):9109-20
references.pmid: 17596307
references.citation: J Virol. 2004 Aug;78(15):8191-200
references.pmid: 15254190
references.citation: Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):21081-6
references.pmid: 23204437
references.citation: J Biol Chem. 2006 Dec 8;281(49):37652-60
references.pmid: 17035242
references.citation: Cell. 2008 Feb 8;132(3):422-33
references.pmid: 18237772
references.citation: J Gen Virol. 1992 Sep;73 ( Pt 9):2385-93
references.pmid: 1328493
references.citation: Curr Biol. 2000 Jul 13;10(14):853-6
references.pmid: 10899010
references.citation: J Virol. 2006 Mar;80(5):2358-68
references.pmid: 16474142
references.citation: Cell. 2009 Jun 26;137(7):1194-211
references.pmid: 19563753
references.citation: J Virol. 1995 Oct;69(10):6533-40
references.pmid: 7666555
references.citation: J Virol. 2007 May;81(10):5192-201
references.pmid: 17267480
references.citation: J Virol. 2006 Aug;80(16):8006-18
references.pmid: 16873257
references.citation: Development. 2012 Mar;139(6):1045-57
references.pmid: 22354838
references.citation: PLoS Pathog. 2011 Aug;7(8):e1002140
references.pmid: 21876668
references.citation: J Virol. 1984 Jan;49(1):190-9
references.pmid: 6317889
references.citation: J Virol. 1999 Oct;73(10):8320-9
references.pmid: 10482582
references.citation: J Virol. 1990 Apr;64(4):1556-65
references.pmid: 2157043
references.citation: J Virol. 1997 Feb;71(2):1246-55
references.pmid: 8995648
references.citation: Cell Host Microbe. 2012 Aug 16;12(2):233-45
references.pmid: 22901543
references.citation: EMBO J. 2012 Nov 5;31(21):4165-78
references.pmid: 23010778
references.citation: J Biotechnol. 2010 Jun;147(3-4):160-3
references.pmid: 20416345
references.citation: J Biomed Biotechnol. 2011;2011:124595
references.pmid: 21048927
references.citation: Cell. 2013 Mar 14;152(6):1285-97
references.pmid: 23498937
references.citation: Epigenomics. 2012 Feb;4(1):67-80
references.pmid: 22332659
references.citation: Nucleic Acids Res. 1991 Jul 25;19(14):3979-86
references.pmid: 1650459
references.citation: Protein Expr Purif. 2006 Jan;45(1):115-24
references.pmid: 16289982
references.citation: Nucleic Acids Res. 2008 Jan;36(Database issue):D83-7
references.pmid: 17981843
references.citation: Nature. 2008 Feb 14;451(7180):796-801
references.pmid: 18235444
references.citation: Intervirology. 1996;39(5-6):343-9
references.pmid: 9130044
references.citation: J Virol. 2009 Apr;83(7):2839-50
references.pmid: 19144709
references.citation: J Virol. 1997 Jun;71(6):4599-613
references.pmid: 9151854
references.citation: Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8309-14
references.pmid: 18550811
references.citation: EMBO J. 2008 Feb 20;27(4):654-66
references.pmid: 18219272
references.citation: PLoS Pathog. 2010 Aug 12;6(8):e1001048
references.pmid: 20730088
references.citation: FEMS Microbiol Rev. 1999 Jul;23(4):457-82
references.pmid: 10422262
references.citation: Pharmacol Ther. 2003 Jun;98(3):269-97
references.pmid: 12782241
references.citation: Cell. 2007 Mar 23;128(6):1231-45
references.pmid: 17382889
references.citation: Arch Virol. 2000;145(6):1257-66
references.pmid: 10948998
references.citation: Nature. 2011 Nov 3;479(7371):74-9
references.pmid: 21964334
references.citation: J Virol. 1991 Feb;65(2):897-903
references.pmid: 1846204
references.citation: Cell. 1999 Nov 24;99(5):459-62
references.pmid: 10589674
references.citation: J Gen Virol. 2011 Sep;92(Pt 9):2006-2019
references.pmid: 21632568
references.citation: Nucleic Acids Res. 2014 Jan;42(2):774-89
references.pmid: 24121688
references.citation: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17234-9
references.pmid: 15572445
references.citation: J Virol. 1987 Feb;61(2):526-33
references.pmid: 3027381
references.citation: EMBO J. 2002 Mar 1;21(5):1112-20
references.pmid: 11867539
references.citation: EMBO J. 1986 Jun;5(6):1367-71
references.pmid: 3015602
references.citation: J Virol. 2011 Sep;85(18):9447-58
references.pmid: 21734036